Dr. Hirofumi Hashimoto, MD

Dr. Hashimoto practices at Sutter Santa Rosa Regional Hospital in Santa Rosa, California, part of Sutter Health.

Dr. Hashimoto's NPI, 1104812585, was assigned on September 21, 2005. Dr. Hashimoto graduated from Stanford University School Of Medicine in 1993. Dr. Hashimoto holds California license G83463.

Dr. Hashimoto's primary practice is Sutter Santa Rosa Regional Hospital, at 30 Mark West Springs Road, Santa Rosa, CA 95403 in Sonoma County. The practice phone is (707) 576-4000.

Dr. Hashimoto's primary practice is Sutter Santa Rosa Regional Hospital in Santa Rosa, California, part of Sutter Health. Dr. Hashimoto is also affiliated with Adventist Health St. Helena. The medical group on file is Pacific Inpatient Medical Group. Dmand AI also links Dr. Hashimoto to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hashimoto practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hashimoto's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Hashimoto is board certified in diplomate by the American Board Integrative and Holistic Medicine. Dmand AI has Dr. Hashimoto's licenses on file in 4 states: California, Colorado, Illinois and Tennessee.

Dmand AI lists acute respiratory failure, cardiac arrhythmia, chronic hypertension, circulatory problems in extremities, congestive heart failure, heart attack, mini-stroke (TIA) and pancreatitis among the conditions Dr. Hashimoto treats.

CMS data shows 381 Medicare services from Dr. Hashimoto across 5 procedure codes in 2024, for 122 Medicare patients. Medicare paid $35,706 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 122 Medicare patients who saw Dr. Hashimoto in 2024. The largest group is 75 to 84, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hashimoto's median patient age at 77, with 50% women.

In 2024, Dr. Hashimoto wrote 109 Medicare Part D claims for 41 patients. 91% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $190 in total drug cost. In 2020, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hashimoto for performance year 2024, reported as part of a group. Dr. Hashimoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Hashimoto, published from 2012 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Cooperative Behavior, Ecosystem and Environmental Monitoring. Dr. Hashimoto has published most often in Front Psychol.

CMS Open Payments shows 1 general payment to Dr. Hashimoto from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $97.

Dmand AI lists 2 awards for Dr. Hashimoto, most recently Compassionate Doctor Award in 2014.

Dr. Hashimoto graduated from Stanford University School Of Medicine in 1993. Dr. Hashimoto is a member of SHM.

Dr. Hashimoto is in network with 2 carriers, including HCSC and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.